Industry seeks incentive to develop rare disease devices
This article was originally published in Clinica
Executive Summary
The European medical devices industry association, EUCOMED, is canvassing its members to test the level of support for its proposal to lobby for the same benefits as those enjoyed by the pharmaceutical industry in the development and marketing of products for rare diseases, known as orphan products.